Acute respiratory distress syndrome

15 clinical trials

Quick filters

Clinical trials for Acute respiratory distress syndrome

15 trials across Europe

See all trials →

Quick filters

15 Clinical trials

Acute respiratory distress syndrome

Recruiting

Investigational

Study of inhaled aprotinin for treatment of moderate to severe acute respiratory distress syndrome

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:APROTININ
Sponsor:Fundacion Del Hospital Nacional De Paraplejicos Para La Investigacion Y La Integracion

Contact Research Centre

Acute respiratory distress syndrome+2

Recruiting

Registered drugNo placebo

Study on Anticoagulation Strategies with Heparin, Enoxaparin, and Argatroban for Patients with Respiratory or Circulatory Failure on ECMO Support

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Enoxaparin Sodium
Sponsor:Medical University Of Vienna

Contact Research Centre

Acute respiratory distress syndrome

Recruiting

Registered drug

Study of High-Dose Vitamin C (Ascorbic Acid) Compared to Placebo in Patients with Sepsis and Acute Respiratory Distress Syndrome (ARDS) in Intensive Care

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Sodium Ascorbate
Sponsor:Assistance Publique Hopitaux De Paris

Contact Research Centre

Acute respiratory distress syndrome

Recruiting

Investigational

Study on the Safety and Benefits of Recombinant Human Plasma Gelsolin for Patients with Moderate-to-Severe Acute Respiratory Distress Syndrome (ARDS)

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:Human Plasma Gelsolin, Recombinant
Sponsor:Bioaegis Therapeutics Inc.

Contact Research Centre

Acute respiratory distress syndrome

Recruiting

Registered drug

Study on Dornase Alfa and Placebo to Reduce ARDS in Ventilated Trauma Patients in ICU

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Dornase Alfa
Sponsor:Les Hopitaux Universitaires De Strasbourg

Contact Research Centre

Acute respiratory distress syndrome

Recruiting

InvestigationalNo placebo

Study on [68Ga]FAPI-46 to Detect Fibroblast Activity in Patients with Non-Resolving Acute Respiratory Distress Syndrome (ARDS) in the ICU

InvestigationalNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:(S)-2,2',2''-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
Sponsor:Universitair Medisch Centrum Groningen

Contact Research Centre

See all trials →

Acute respiratory distress syndrome

Clinical trials for Acute respiratory distress syndrome

Acute respiratory distress syndrome

Study of inhaled aprotinin for treatment of moderate to severe acute respiratory distress syndrome

Acute respiratory distress syndrome+2

Study on Anticoagulation Strategies with Heparin, Enoxaparin, and Argatroban for Patients with Respiratory or Circulatory Failure on ECMO Support

Acute respiratory distress syndrome

Study of High-Dose Vitamin C (Ascorbic Acid) Compared to Placebo in Patients with Sepsis and Acute Respiratory Distress Syndrome (ARDS) in Intensive Care

Acute respiratory distress syndrome

Study on the Safety and Benefits of Recombinant Human Plasma Gelsolin for Patients with Moderate-to-Severe Acute Respiratory Distress Syndrome (ARDS)

Acute respiratory distress syndrome

Study on Dornase Alfa and Placebo to Reduce ARDS in Ventilated Trauma Patients in ICU

Acute respiratory distress syndrome

Study on [68Ga]FAPI-46 to Detect Fibroblast Activity in Patients with Non-Resolving Acute Respiratory Distress Syndrome (ARDS) in the ICU

Filter the trials

Prefer not to search? Our Concierge searches the trials for you.